同泰生物 (871354.OC)

+ 收藏

财务摘要(报告期)(同泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) -0.040.220.140.240.14
 每股收益 - 稀释(元) -0.040.220.140.240.14
 每股收益 - 期末股本摊薄(元) -0.040.220.140.220.14
 每股净资产BPS(元) 3.873.913.843.703.17
 每股经营活动产生的现金流量净额(元) -0.13-0.170.01-0.090.14
 每股营业收入(元) 0.301.040.490.950.62
关键比率:
 净资产收益率 - 摊薄(%) -1.045.583.675.884.40
 净资产收益率 - 加权(%) -1.03-3.737.104.50
 净资产收益率 - 平均(%) -1.035.743.736.944.50
 净资产收益率 - 扣除(%) -1.045.873.705.714.33
 总资产净利率 - 平均(%) -0.824.613.055.122.91
 总资产报酬率ROA(%) -0.405.853.827.174.32
 投入资本回报率ROIC(%) -0.445.743.616.974.42
 销售毛利率(%) 37.8961.9865.2860.0057.54
 销售净利率(%) -13.3120.9328.6622.8822.61
 资产负债率(%) 21.2820.2617.4919.0436.03
 资产周转率(倍) 0.060.220.110.220.13
 销售商品提供劳务收到的现金/营业收入(%) 26.8344.0747.1662.1045.21
 营业利润同比增长率(%) -124.25-2.665.87-4.89111.49
 营业收入同比增长率(%) -38.429.99-6.00-7.3329.73
 利润总额同比增长率(%) -124.59-9.155.12-5.12110.04
 归属母公司股东的净利润同比增长率(%) -128.600.6219.17-4.3767.65
 扣非后归属母公司股东的净利润同比增长率(%) -128.368.8722.33-0.4280.09
 总资产同比增长率(%) 5.847.5310.8616.7523.78
 总负债同比增长率(%) 28.7814.40-46.18-35.3842.67
 净资产同比增长率(%) 0.985.9142.9844.0815.19
利润表摘要:
 营业总收入(元) 22,886,409.0879,034,850.9137,162,423.1171,855,326.5039,533,396.98
 营业总成本(元) 21,696,252.7849,784,226.6422,759,243.3749,285,510.8926,532,746.61
 营业收入(元) 22,886,409.0879,034,850.9137,162,423.1171,855,326.5039,533,396.98
 营业利润(元) -3,027,093.3919,933,697.1312,481,518.5520,479,325.9911,789,970.70
 利润总额(元) -3,026,655.5518,431,252.2112,308,401.2720,287,475.6111,708,911.31
 净利润(元) -3,045,861.7416,545,257.6510,651,205.6116,443,649.948,938,066.91
 归属母公司股东的净利润(元) -3,045,861.7416,545,257.6510,651,205.6116,443,649.948,938,066.91
 非经常性损益(元) 2,555.82-858,099.25-99,629.56457,517.07149,596.48
 归属母公司股东的净利润扣除非经常性损益(元) -3,048,417.5617,403,356.9010,750,835.1715,986,132.878,788,470.43
资产负债表摘要:
 流动资产(元) 230,029,026.99223,704,218.68195,527,502.20192,602,700.13188,587,596.89
 固定资产(元) 49,816,914.0653,223,991.4261,788,675.0165,959,924.4850,491,038.72
 资产总计(元) 372,689,553.53371,703,106.28352,113,075.49345,678,657.79317,624,354.34
 流动负债(元) 64,352,161.1865,082,402.3453,090,378.4253,517,746.3297,792,929.09
 非流动负债(元) 14,969,186.8810,206,636.738,502,681.9012,292,101.9116,648,194.76
 负债合计(元) 79,321,348.0675,289,039.0761,593,060.3265,809,848.23114,441,123.85
 股东权益(元) 293,368,205.47296,414,067.21290,520,015.17279,868,809.56203,183,230.49
 归属母公司股东的权益(元) 293,368,205.47296,414,067.21290,520,015.17279,868,809.56203,183,230.49
 资本公积(元) 123,419,327.45123,419,327.45123,419,327.45123,419,327.4565,905,997.41
 盈余公积(元) 7,454,545.637,454,545.635,722,665.755,729,713.805,059,703.21
 未分配利润(元) 86,777,666.3989,823,528.1385,661,355.9775,003,102.3168,167,529.87
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 6,140,549.7234,831,034.8017,527,355.2444,620,418.3517,873,876.24
 经营活动产生的现金净流量(元) -9,519,229.15-12,927,851.29938,916.24-6,952,361.939,033,360.20
 购建固定无形长期资产支付的现金(元) 1,146,196.0019,014,994.4210,387,815.8942,793,971.8726,884,935.98
 投资活动产生的现金净流量(元) -1,146,196.00-10,794,994.42-10,387,815.89-55,389,729.87-26,871,149.98
 吸收投资收到的现金(元) ---69,999,996.00-
 取得借款收到的现金(元) 7,694,000.0050,700,000.009,000,000.0044,000,000.006,000,000.00
 筹资活动产生的现金净流量(元) -1,066,714.338,533,540.00-5,377,646.9561,081,069.09-2,696,320.75
 现金及现金等价物净增加(元) -11,732,139.48-15,189,305.71-14,826,546.60-1,261,022.71-20,534,110.53
 期末现金及现金等价物余额(元) 45,538.3211,777,677.8012,140,436.9126,966,983.517,693,895.69
 折旧与摊销(元) 6,168,229.8614,731,959.687,760,821.6713,900,088.924,999,281.77
公告日期 2024-08-272024-04-192023-08-252023-04-202022-08-22
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院